SalutarisMD Presents Data for Wet AMD Treatment with Long Term Positive Outcomes at Association for Research in Vision & Ophthalmology
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
At the Association for Research in Vision and Ophthalmology, Inc. (ARVO) Annual Meeting yesterday, Kamaljit Balaggan, BSc (Hons), MBBS, MRCOphth, PhD, Vitreoretinal Surgery Fellow at Moorfields Eye Hospital National Health Service (NHS) Foundation Trust in London, presented results from a cohort study evaluating the use of a minimally invasive retrobulbar episcleral brachytherapy device developed by Salutaris Medical Devices (SalutarisMD™) to treat Wet AMD (Age-related Macular Degeneration), the leading cause of vision loss and blindness.
Help employers find you! Check out all the jobs and post your resume.
At the Association for Research in Vision and Ophthalmology, Inc. (ARVO) Annual Meeting yesterday, Kamaljit Balaggan, BSc (Hons), MBBS, MRCOphth, PhD, Vitreoretinal Surgery Fellow at Moorfields Eye Hospital National Health Service (NHS) Foundation Trust in London, presented results from a cohort study evaluating the use of a minimally invasive retrobulbar episcleral brachytherapy device developed by Salutaris Medical Devices (SalutarisMD™) to treat Wet AMD (Age-related Macular Degeneration), the leading cause of vision loss and blindness.
Help employers find you! Check out all the jobs and post your resume.